Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL471726 | 1.00 | PDE4A (0.41) | PDE4ALMNAAKR1B1L3MBTL1TDP1 | |
| SCHEMBL29720316 | 1.00 | PDE4A (0.41) | PDE4ALMNAAKR1B1L3MBTL1TDP1 | |
| SCHEMBL817588 | 1.00 | PDE4A (0.41) | PDE4ALMNAAKR1B1L3MBTL1TDP1 | |
| SCHEMBL29506762 | 0.85 | PDE4A (0.48) | PDE4ALMNAAKR1B1L3MBTL1TDP1 | |
| SCHEMBL15948731 | 0.85 | PDE4A (0.48) | PDE4ALMNAAKR1B1L3MBTL1TDP1 | |
| SCHEMBL5919108 | 0.85 | PDE4A (0.48) | PDE4ALMNAAKR1B1L3MBTL1TDP1 | |
| SCHEMBL29375023 | 0.85 | PDE4A (0.48) | PDE4ALMNAAKR1B1L3MBTL1TDP1 | |
| SCHEMBL818364 | 0.85 | PDE4A (0.48) | PDE4ALMNAAKR1B1L3MBTL1TDP1 | |
| SCHEMBL29502274 | 0.85 | PDE4A (0.48) | PDE4ALMNAAKR1B1L3MBTL1TDP1 | |
| SCHEMBL4258412 | 0.85 | PDE4A (0.48) | PDE4ALMNAAKR1B1L3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117317164-A | Preparation method of metal alloy doped hard carbon alloy material | 晖阳(贵州)新能源材料有限公司 | 2023-12-29 | — | — | CN | claimed |
| US-20240367975-A1 | CONVERSION OF NITROGEN DIOXIDE (NO2) TO NITRIC OXIDE (NO) | VERO BIOTECH INC. | 2024-11-07 | — | — | US | disclosed |
| US-20240288410-A1 | SELECTIVE OPTICAL AQUEOUS AND NONAQUEOUS DETECTION OF FREE SULFITES | UNIV NEW YORK STATE RES FOUND (US) | 2024-08-29 | — | — | US | disclosed |
| US-11884541-B2 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | VERO BIOTECH INC. (US) | 2024-01-30 | — | — | US | disclosed |
| CN-117317164-A | Preparation method of metal alloy doped hard carbon alloy material | 晖阳(贵州)新能源材料有限公司 | 2023-12-29 | — | — | CN | disclosed |
| US-20230077727-A1 | CONVERSION OF NITROGEN DIOXIDE (NO2) TO NITRIC OXIDE (NO) | VERO BIOTECH INC. (US) | 2023-03-16 | — | — | US | disclosed |
| EP-3692366-B1 | SELECTIVE OPTICAL AQUEOUS AND NON-AQUEOUS DETECTION OF FREE SULFITES | UNIV NEW YORK STATE RES FOUND (US) | 2022-12-14 | — | — | EP | disclosed |
| US-11312626-B2 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | VERO BIOTECH INC. (US) | 2022-04-26 | — | — | US | disclosed |
| US-20200180958-A1 | CONVERSION OF NITROGEN DIOXIDE (NO2) TO NITRIC OXIDE (NO) | Vero Biotech LLC (US) | 2020-06-11 | — | — | US | disclosed |
| US-20190092639-A1 | CONVERSION OF NITROGEN DIOXIDE (NO2) TO NITRIC OXIDE (NO) | Vero Biotech LLC (US) | 2019-03-28 | — | — | US | disclosed |
| US-20140271939-A1 | CONVERSION OF NITROGEN DIOXIDE (NO2) TO NITRIC OXIDE (NO) | HORIZON TECHNOLOGY FINANCE CORPORATION | 2014-09-18 | — | — | US | disclosed |
| US-8741222-B2 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | GENO LLC (US) | 2014-06-03 | — | — | US | disclosed |
| US-8609026-B2 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | GENO LLC (US) | 2013-12-17 | — | — | US | disclosed |
| US-20120238031-A1 | Conversion of Nitrogen Dioxide (NO2) to Nitric Oxide (NO) | HORIZON TECHNOLOGY FINANCE CORPORATION | 2012-09-20 | — | — | US | disclosed |
| US-8187544-B2 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | GENO LLC (US) | 2012-05-29 | — | — | US | disclosed |
| US-20110168174-A1 | Conversion of Nitrogen Dioxide (NO2) to Nitric Oxide (NO) | VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC) | 2011-07-14 | — | — | US | disclosed |
| US-7914743-B2 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | GENO LLC (US) | 2011-03-29 | — | — | US | disclosed |
| EP-2247381-A1 | CONVERSION OF NITROGEN DIOXIDE (NO2) TO NITRIC OXIDE (NO) | Geno LLC (US) | 2010-11-10 | — | — | EP | disclosed |
| US-20090314289-A1 | Conversion of Nitrogen Dioxide (NO2) to Nitric Oxide (NO) | HORIZON TECHNOLOGY FINANCE CORPORATION | 2009-12-24 | — | — | US | disclosed |
| WO-2009097343-A1 | CONVERSION OF NITROGEN DIOXIDE (NO2) TO NITRIC OXIDE (NO) | GENO LLC (US) | 2009-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240288410-A1 | SELECTIVE OPTICAL AQUEOUS AND NONAQUEOUS DETECTION OF FREE SULFITES | PRDX4, PTPN12, PTPN4 | PDE4A 145/4885LMNA 4644/4885AKR1B1 4114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.